MSBHF(MSBHF)
MSBHF
No analyst ratings available
No analyst price targets available for MSBHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $20.35T | $20.90T | $21.37T | $23.58T | $23.93T |
| Low | $18.66T | $19.17T | $19.59T | $21.62T | $21.94T |
| High | $22.22T | $22.83T | $23.33T | $25.74T | $26.12T |
| EBITDA Avg | $1.14T | $1.17T | $1.20T | $1.32T | $1.34T |
| Low | $1.05T | $1.08T | $1.10T | $1.21T | $1.23T |
| High | $1.25T | $1.28T | $1.31T | $1.44T | $1.47T |
| EBIT Avg | $468.00B | $480.73B | $491.33B | $542.19B | $550.19B |
| Low | $429.16B | $440.83B | $450.54B | $497.19B | $504.53B |
| High | $511.00B | $524.90B | $536.47B | $592.01B | $600.74B |
| Net Income Avg | $1.26T | $1.24T | $1.28T | $1.34T | $1.37T |
| Low | $1.12T | $1.10T | $1.15T | $1.19T | $1.22T |
| High | $1.41T | $1.39T | $1.44T | $1.49T | $1.53T |
| EPS Avg | $329.74 | $324.41 | $336.48 | $349.88 | $358.81 |
| Low | $294.16 | $289.40 | $300.17 | $312.12 | $320.09 |
| High | $369.13 | $363.15 | $376.67 | $391.67 | $401.66 |
| Analysts (Rev / EPS) | 2 / 1 | 3 / 1 | 1 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $4.57T | $5.22T | $5.42T | $4.50T | $4.71T | $5.38T | $5.58T | $4.63T |
| Low | $4.57T | $5.22T | $5.42T | $4.50T | $4.71T | $5.38T | $5.58T | $4.63T |
| High | $4.57T | $5.22T | $5.42T | $4.50T | $4.71T | $5.38T | $5.58T | $4.63T |
| EBITDA Avg | $256.60B | $292.84B | $303.96B | $252.32B | $264.30B | $301.63B | $313.03B | $259.88B |
| Low | $256.60B | $292.84B | $303.96B | $252.32B | $264.30B | $301.63B | $313.03B | $259.88B |
| High | $256.60B | $292.84B | $303.96B | $252.32B | $264.30B | $301.63B | $313.03B | $259.88B |
| EBIT Avg | $105.18B | $120.04B | $124.59B | $103.42B | $108.34B | $123.64B | $128.31B | $106.53B |
| Low | $105.18B | $120.04B | $124.59B | $103.42B | $108.34B | $123.64B | $128.31B | $106.53B |
| High | $105.18B | $120.04B | $124.59B | $103.42B | $108.34B | $123.64B | $128.31B | $106.53B |
| Net Income Avg | $208.44B | $248.76B | $494.01B | $242.57B | $217.44B | $262.09B | $399.51B | $218.66B |
| Low | $208.44B | $248.76B | $494.01B | $242.57B | $217.44B | $262.09B | $399.51B | $218.66B |
| High | $208.44B | $248.76B | $494.01B | $242.57B | $217.44B | $262.09B | $399.51B | $218.66B |
| EPS Avg | $56.61 | $67.56 | $134.18 | $65.88 | $59.06 | $71.18 | $108.51 | $59.39 |
| Low | $56.61 | $67.56 | $134.18 | $65.88 | $59.06 | $71.18 | $108.51 | $59.39 |
| High | $56.61 | $67.56 | $134.18 | $65.88 | $59.06 | $71.18 | $108.51 | $59.39 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |